Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus
Date first appeared online 31/12/2011
DOI 10.1016/j.diabres.2011.07.014
Authors Stephens J., Prior S., Bracken R., Dunseath G., Luzio S.
Journal Name Diabetes Research and Clinical Practice
Volume 94

Documents